Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04454463 · ClinicalTrials.gov registry record
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
A clinical trial, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- 1,649
- Enrollment target
NCT04454463 is a clinical trial that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 1,649 participants.
The verdict
NCT04454463 has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- 1,649 participants
- Enrollment target
Study Summary
The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,649 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2025-07-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04454463
The ClinicalTrials.gov registry entry for NCT04454463 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,649 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04454463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04454463 about?
NCT04454463 is a clinical study titled "Nonalcoholic Fatty Liver Disease (NAFLD) Database 3". The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnos...
What is the current status of trial NCT04454463?
This trial is currently completed. The enrollment target is 1,649 participants. The study started on 2020-11-13. Estimated completion is 2025-07-09.
Who is sponsoring clinical trial NCT04454463?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.